Literature DB >> 14559097

Targeting virulence for antimicrobial chemotherapy.

Yvonne M Lee1, Fredrik Almqvist, Scott J Hultgren.   

Abstract

Untreatable bacterial infections constitute a dark but valid threat, with numbers of antibiotic resistant pathogens, as well as newly emerging ones, rising quickly. To combat this dangerous prospect, growing research into antimicrobials could be aimed at targeting the virulence of pathogens. Virulence refers to an organism's ability to establish an infection and cause disease. Many steps involved in the infection process can be targeted, including adherence, invasion and host defense evasion. Identification and characterization of virulence factors that aid in bacterial pathogenicity will lead to new drugs that can be applied to a variety of pathogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559097     DOI: 10.1016/j.coph.2003.04.001

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  20 in total

Review 1.  The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors.

Authors:  L Hedstrom; G Liechti; J B Goldberg; D R Gollapalli
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Dissecting novel virulent determinants in the Burkholderia cepacia complex.

Authors:  George P Tegos; Mark K Haynes; Herbert P Schweizer
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

3.  The C-terminal repeating units of CsgB direct bacterial functional amyloid nucleation.

Authors:  Neal D Hammer; Bryan A McGuffie; Yizhou Zhou; Matthew P Badtke; Ashley A Reinke; Kristoffer Brännström; Jason E Gestwicki; Anders Olofsson; Fredrik Almqvist; Matthew R Chapman
Journal:  J Mol Biol       Date:  2012-06-07       Impact factor: 5.469

4.  Catalysis of protein folding by chaperones in pathogenic bacteria.

Authors:  James G Bann; Jerome S Pinkner; Carl Frieden; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

5.  Small-molecule inhibitors specifically targeting type III secretion.

Authors:  R Nordfelth; A M Kauppi; H A Norberg; H Wolf-Watz; M Elofsson
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 6.  DSB proteins and bacterial pathogenicity.

Authors:  Begoña Heras; Stephen R Shouldice; Makrina Totsika; Martin J Scanlon; Mark A Schembri; Jennifer L Martin
Journal:  Nat Rev Microbiol       Date:  2009-02-09       Impact factor: 60.633

Review 7.  The biology and future prospects of antivirulence therapies.

Authors:  Lynette Cegelski; Garland R Marshall; Gary R Eldridge; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2008-01       Impact factor: 60.633

Review 8.  Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.

Authors:  Laurel K Mydock-McGrane; Thomas J Hannan; James W Janetka
Journal:  Expert Opin Drug Discov       Date:  2017-06-02       Impact factor: 6.098

Review 9.  All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease.

Authors:  Tyler G St Denis; Tianhong Dai; Leonid Izikson; Christos Astrakas; Richard Rox Anderson; Michael R Hamblin; George P Tegos
Journal:  Virulence       Date:  2011-11-01       Impact factor: 5.882

Review 10.  Protein Disulfide Exchange by the Intramembrane Enzymes DsbB, DsbD, and CcdA.

Authors:  John H Bushweller
Journal:  J Mol Biol       Date:  2020-04-16       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.